Renibus Therapeutics Announces Poster Presentation on RBT-1 at the 47th Annual Meeting of the Society of Cardiovascular Anesthesiologists (SCA)
Renibus Therapeutics Announces Poster Presentation on RBT-1 at the [...]
Renibus Therapeutics Announces Completion of Enrollment in PROTECT, a Pivotal Phase 3 Clinical Trial of RBT-1 to Reduce the Risk of Post-Operative Complications After Cardiac Surgery
Renibus Therapeutics Announces Completion of Enrollment in PROTECT, a Pivotal [...]
Renibus to Participate in the 24th Annual Needham Healthcare Virtual Healthcare Conference
Renibus to Participate in the 24th Annual Needham Healthcare Virtual [...]
Renibus to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
Renibus to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences [...]
Renibus Therapeutics Announces Oral Presentation on RBT-1 at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
Renibus Therapeutics Announces Oral Presentation on RBT-1 at the 38th [...]
Renibus Therapeutics Presents Two Posters on RBT-1 , a First-in-Class Preconditioning Agent, at the Academy of Managed Care Pharmacy (AMCP) Nexus 2024 Meeting
Renibus Therapeutics Presents Two Posters on RBT-1 , a [...]
Renibus Therapeutics Announces Participation at Upcoming Investor Conferences
Renibus Therapeutics Announces Participation at Upcoming Investor Conferences [...]
Renibus Therapeutics Announces Oral Presentations on RBT-1 at AATS and SCA Medical Conferences
Renibus Therapeutics Announces Oral Presentations on RBT-1 at AATS [...]
Renibus Therapeutics Announces Oral Presentation on RBT-1 at the European Association for Cardio-Thoracic Surgery (EACTS) 2nd Innovation Summit
Renibus Therapeutics Announces Oral Presentation on RBT-1 at the [...]
Renibus Announces Participation at the 23rd Annual Needham Virtual Healthcare Conference
Renibus Announces Participation at the 23rd Annual Needham Virtual Healthcare [...]